Monitoring specific T-cell responses to melanoma vaccines: ELISPOT, tetramers, and beyond

Clinical and Diagnostic Laboratory Immunology

Volumn 7, Issue 2, 2000, Pages 141-144

  Gajewski, T F ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; HLA A2 ANTIGEN; MELANOMA ANTIGEN; MELANOMA VACCINE; TETRAMER;

ACCURACY; ANTIGEN SPECIFICITY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSPOT ASSAY; HUMAN; IMMUNOASSAY; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MELANOMA; NOTE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

CANCER VACCINES; CD8-POSITIVE T-LYMPHOCYTES; FORECASTING; HUMANS; MAJOR HISTOCOMPATIBILITY COMPLEX; MELANOMA; PEPTIDES; T-LYMPHOCYTES;

EID: 0034094357     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.7.2.141-144.2000     Document Type: Note

References (18)